Genome-wide array-based comparative genomic hybridization reveals multiple amplification targets and novel homozygous deletions in pancreatic carcinoma cell lines - PubMed (original) (raw)
Genome-wide array-based comparative genomic hybridization reveals multiple amplification targets and novel homozygous deletions in pancreatic carcinoma cell lines
Markus Heidenblad et al. Cancer Res. 2004.
Abstract
Pancreatic carcinomas display highly complex chromosomal abnormalities, including many structural and numerical aberrations. There is ample evidence indicating that some of these abnormalities, such as recurrent amplifications and homozygous deletions, contribute to tumorigenesis by altering expression levels of critical oncogenes and tumor suppressor genes. To increase the understanding of gene copy number changes in pancreatic carcinomas and to identify key amplification/deletion targets, we applied genome-wide array-based comparative genomic hybridization to 31 pancreatic carcinoma cell lines. Two different microarrays were used, one containing 3,565 fluorescence in situ hybridization-verified bacterial artificial chromosome clones and one containing 25,468 cDNA clones representing 17,494 UniGene clusters. Overall, the analyses revealed a high genomic complexity, with several copy number changes detected in each case. Specifically, 60 amplicons at 32 different locations were identified, most frequently located within 8q (8 cases), 12p (7 cases), 7q (5 cases), 18q (5 cases), 19q (5 cases), 6p (4 cases), and 8p (4 cases). Amplifications of 8q and 12p were mainly clustered at 8q23-24 and 12p11-12, respectively, whereas amplifications on other chromosome arms were more dispersed. Furthermore, our analyses identified several novel homozygously deleted segments located to 9p24, 9p21, 9q32, 10p12, 10q22, 12q24, and 18q23. The individual complexity and aberration patterns varied substantially among cases, i.e., some cell lines were characterized mainly by high-level amplifications, whereas others showed primarily whole-arm imbalances and homozygous deletions. The described amplification and deletion targets are likely to contain genes important in pancreatic tumorigenesis.
Similar articles
- Array-based comparative genomic hybridization identifies localized DNA amplifications and homozygous deletions in pancreatic cancer.
Bashyam MD, Bair R, Kim YH, Wang P, Hernandez-Boussard T, Karikari CA, Tibshirani R, Maitra A, Pollack JR. Bashyam MD, et al. Neoplasia. 2005 Jun;7(6):556-62. doi: 10.1593/neo.04586. Neoplasia. 2005. PMID: 16036106 Free PMC article. - Detailed genomic mapping and expression analyses of 12p amplifications in pancreatic carcinomas reveal a 3.5-Mb target region for amplification.
Heidenblad M, Jonson T, Mahlamäki EH, Gorunova L, Karhu R, Johansson B, Höglund M. Heidenblad M, et al. Genes Chromosomes Cancer. 2002 Jun;34(2):211-23. doi: 10.1002/gcc.10063. Genes Chromosomes Cancer. 2002. PMID: 11979555 - Identification of SMURF1 as a possible target for 7q21.3-22.1 amplification detected in a pancreatic cancer cell line by in-house array-based comparative genomic hybridization.
Suzuki A, Shibata T, Shimada Y, Murakami Y, Horii A, Shiratori K, Hirohashi S, Inazawa J, Imoto I. Suzuki A, et al. Cancer Sci. 2008 May;99(5):986-94. doi: 10.1111/j.1349-7006.2008.00779.x. Cancer Sci. 2008. PMID: 18380791 Free PMC article. - Genome-wide analysis of pancreatic cancer using microarray-based techniques.
Harada T, Chelala C, Crnogorac-Jurcevic T, Lemoine NR. Harada T, et al. Pancreatology. 2009;9(1-2):13-24. doi: 10.1159/000178871. Epub 2008 Dec 12. Pancreatology. 2009. PMID: 19077451 Review. - Molecular cytogenetic characterization of pancreas cancer cell lines reveals high complexity chromosomal alterations.
Griffin CA, Morsberger L, Hawkins AL, Haddadin M, Patel A, Ried T, Schrock E, Perlman EJ, Jaffee E. Griffin CA, et al. Cytogenet Genome Res. 2007;118(2-4):148-56. doi: 10.1159/000108295. Cytogenet Genome Res. 2007. PMID: 18000365 Review.
Cited by
- The molecular and cellular heterogeneity of pancreatic ductal adenocarcinoma.
Samuel N, Hudson TJ. Samuel N, et al. Nat Rev Gastroenterol Hepatol. 2011 Dec 20;9(2):77-87. doi: 10.1038/nrgastro.2011.215. Nat Rev Gastroenterol Hepatol. 2011. PMID: 22183185 Review. - Kank proteins: structure, functions and diseases.
Kakinuma N, Zhu Y, Wang Y, Roy BC, Kiyama R. Kakinuma N, et al. Cell Mol Life Sci. 2009 Aug;66(16):2651-9. doi: 10.1007/s00018-009-0038-y. Epub 2009 May 12. Cell Mol Life Sci. 2009. PMID: 19554261 Free PMC article. Review. - Genetic and pharmacological inhibition of TTK impairs pancreatic cancer cell line growth by inducing lethal chromosomal instability.
Stratford JK, Yan F, Hill RA, Major MB, Graves LM, Der CJ, Yeh JJ. Stratford JK, et al. PLoS One. 2017 Apr 5;12(4):e0174863. doi: 10.1371/journal.pone.0174863. eCollection 2017. PLoS One. 2017. PMID: 28380042 Free PMC article. - Genome-wide array-based comparative genomic hybridization analysis of pancreatic adenocarcinoma: identification of genetic indicators that predict patient outcome.
Loukopoulos P, Shibata T, Katoh H, Kokubu A, Sakamoto M, Yamazaki K, Kosuge T, Kanai Y, Hosoda F, Imoto I, Ohki M, Inazawa J, Hirohashi S. Loukopoulos P, et al. Cancer Sci. 2007 Mar;98(3):392-400. doi: 10.1111/j.1349-7006.2007.00395.x. Epub 2007 Jan 12. Cancer Sci. 2007. PMID: 17233815 Free PMC article. - The role of mirk kinase in sarcomas.
Friedman E. Friedman E. Sarcoma. 2011;2011:260757. doi: 10.1155/2011/260757. Epub 2011 Apr 13. Sarcoma. 2011. PMID: 21559261 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials